PEAK6
MRNA icon

PEAK6’s Moderna MRNA Stock Holding History

PEAK6’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-60,583
Closed -$3.13M – 3051
2026
Q1 		$3.08M Sell
60,583
-35,773
-37% -$1.67M 0.01% 1148
2025
Q4 		$2.84M Sell
96,356
-28,125
-23% -$764K 0.01% 1236
2025
Q3 		$3.22M Sell
124,481
-189,657
-60% -$5.29M ﹤0.01% 1242
2025
Q2 		$8.67M Buy
314,138
+48,888
+18% +$1.29M 0.02% 691
2025
Q1 		$7.52M Buy
265,250
+112,532
+74% +$3.99M 0.02% 702
2024
Q4 		$6.35M Buy
+152,718
New +$7.3M 0.01% 776

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

PEAK6's MRNA Position: Q2 2026 in Review

PEAK6 sold out of Moderna (MRNA) in Q2 2026, closing a stake of 60,583 shares — an estimated $3.13M sold.

PEAK6 first reported a position in MRNA in Q4 2024 and held it in 6 quarters. The position peaked at $8.67M in Q2 2025. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • PEAK6 reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • PEAK6 sold 60,583 Moderna shares in Q2 2026, an estimated $3.13M.
  • PEAK6 first reported a position in Moderna in Q4 2024 and held it in 6 quarters.
  • PEAK6's Moderna position peaked at $8.67M in Q2 2025.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.